Literature DB >> 27660391

TCL/RhoJ Plasma Membrane Localization and Nucleotide Exchange Is Coordinately Regulated by Amino Acids within the N Terminus and a Distal Loop Region.

Karly L Ackermann1, Rebecca R Florke1, Shannon S Reyes1, Brooke R Tader1, Michael J Hamann2.   

Abstract

TCL/RhoJ is a Cdc42-related Rho GTPase with reported activities in endothelial cell biology and angiogenesis, metastatic melanoma, and corneal epithelial cells; however, less is known about how it is inherently regulated in comparison to its closest homologues TC10 and Cdc42. TCL has an N-terminal extension of 18 amino acids in comparison to Cdc42, but the function of this amino acid sequence has not been elucidated. A truncation mutant lacking the N terminus (ΔN) was found to alter TCL plasma membrane localization and nucleotide binding, and additional truncation and point mutants mapped the alterations of TCL biochemistry to amino acids 17-20. Interestingly, whereas the TCL ΔN mutant clearly influenced nucleotide exchange, deletion of the N terminus from its closest homologue, TC10, did not have a similar effect. Chimeras of TCL and TC10 revealed amino acids 121-129 of TCL contributed to the differences in nucleotide loading. Together, these results identify amino acids within the N terminus and a loop region distal to the nucleotide binding pocket of TCL capable of allosterically regulating nucleotide exchange and thus influence membrane association of the protein.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  CDC42; GTPase; Rho (Rho GTPase); RhoJ; TCL; allosteric regulation; cell biology; membrane trafficking; small GTPase; vesicles

Mesh:

Substances:

Year:  2016        PMID: 27660391      PMCID: PMC5095414          DOI: 10.1074/jbc.M116.750026

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  T-Coffee: A novel method for fast and accurate multiple sequence alignment.

Authors:  C Notredame; D G Higgins; J Heringa
Journal:  J Mol Biol       Date:  2000-09-08       Impact factor: 5.469

2.  Negative regulation of Rho family GTPases Cdc42 and Rac2 by homodimer formation.

Authors:  B Zhang; Y Zheng
Journal:  J Biol Chem       Date:  1998-10-02       Impact factor: 5.157

3.  An electrostatic steering mechanism of Cdc42 recognition by Wiskott-Aldrich syndrome proteins.

Authors:  Lars Hemsath; Radovan Dvorsky; Dennis Fiegen; Marie-France Carlier; Mohammad Reza Ahmadian
Journal:  Mol Cell       Date:  2005-10-28       Impact factor: 17.970

4.  RhoJ/TCL regulates endothelial motility and tube formation and modulates actomyosin contractility and focal adhesion numbers.

Authors:  Sukhbir Kaur; Katarzyna Leszczynska; Sabu Abraham; Margherita Scarcia; Sabina Hiltbrunner; Christopher J Marshall; Georgia Mavria; Roy Bicknell; Victoria L Heath
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-12-09       Impact factor: 8.311

5.  Jalview Version 2--a multiple sequence alignment editor and analysis workbench.

Authors:  Andrew M Waterhouse; James B Procter; David M A Martin; Michèle Clamp; Geoffrey J Barton
Journal:  Bioinformatics       Date:  2009-01-16       Impact factor: 6.937

Review 6.  Biochemical analyses of the Wrch atypical Rho family GTPases.

Authors:  Adam Shutes; Anastacia C Berzat; Emily J Chenette; Adrienne D Cox; Channing J Der
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

7.  Rho GTPases have diverse effects on the organization of the actin filament system.

Authors:  Pontus Aspenström; Asa Fransson; Jan Saras
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

8.  Arhgef15 promotes retinal angiogenesis by mediating VEGF-induced Cdc42 activation and potentiating RhoJ inactivation in endothelial cells.

Authors:  Sentaro Kusuhara; Yoko Fukushima; Shigetomo Fukuhara; Lars Martin Jakt; Mitsuhiro Okada; Yuri Shimizu; Masayuki Hata; Kohji Nishida; Akira Negi; Masanori Hirashima; Naoki Mochizuki; Shin-Ichi Nishikawa; Akiyoshi Uemura
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

9.  Depalmitoylated Ras traffics to and from the Golgi complex via a nonvesicular pathway.

Authors:  J Shawn Goodwin; Kimberly R Drake; Carl Rogers; Latasha Wright; Jennifer Lippincott-Schwartz; Mark R Philips; Anne K Kenworthy
Journal:  J Cell Biol       Date:  2005-07-18       Impact factor: 10.539

10.  A comprehensive survey of Ras mutations in cancer.

Authors:  Ian A Prior; Paul D Lewis; Carla Mattos
Journal:  Cancer Res       Date:  2012-05-15       Impact factor: 12.701

View more
  3 in total

1.  Rhoj Is a Novel Target for Progression and Invasion of Glioblastoma by Impairing Cytoskeleton Dynamics.

Authors:  Mei Wang; Xiaochun Jiang; Yongbo Yang; Hongjin Chen; Chengfei Zhang; Haojun Xu; Bin Qi; Chengyun Yao; Hongping Xia
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

2.  Unraveling a model of TCL/RhoJ allosterism using TC10 reverse chimeras.

Authors:  Rebecca R Florke; Grace T Young; Michael J Hamann
Journal:  Small GTPases       Date:  2017-10-03

3.  Structure-based design of CDC42 effector interaction inhibitors for the treatment of cancer.

Authors:  Sohail Jahid; Jose A Ortega; Linh M Vuong; Isabella Maria Acquistapace; Stephanie J Hachey; Jessica L Flesher; Maria Antonietta La Serra; Nicoletta Brindani; Giuseppina La Sala; Jacopo Manigrasso; Jose M Arencibia; Sine Mandrup Bertozzi; Maria Summa; Rosalia Bertorelli; Andrea Armirotti; Rongsheng Jin; Zheng Liu; Chi-Fen Chen; Robert Edwards; Christopher C W Hughes; Marco De Vivo; Anand K Ganesan
Journal:  Cell Rep       Date:  2022-04-05       Impact factor: 9.995

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.